Bedford Laboratories(TM) to Begin Shipping Milrinone Lactate Injection in PVC Flexible Containers

BEDFORD, Ohio, Feb. 16 /PRNewswire/ -- Bedford Laboratories™, a division of Ben Venue Laboratories, Inc., announced the addition of milrinone lactate in 5% dextrose injection (0.2mg / mL) in single-dose PVC flexible containers to its existing milrinone injection line.  This product is AP rated and is equivalent to Primacor® by Sanofi-Aventis.  Milrinone lactate in 5% dextrose injection is a bipyridine inotropic/vasodialator agent indicated for the short-term intravenous treatment of patients with acute decompensated heart failure.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20070809/CLTH157LOGO )

"With this launch, Bedford Laboratories is pleased to offer our second product now available in a PVC flexible container.  I believe this speaks to our commitment to bringing the most comprehensive and cost effective line of injectables to our customers," said David Gaugh, Vice President and General Manager of Bedford Laboratories.

In addition to the three glass vial presentations, Bedford Laboratories will supply milrinone lactate in 5% dextrose injection in two sterile ready-to-use dilutions in the following presentations:  20mg / 100mL in single-dose PVC flexible containers packaged in cartons containing 10 bags and 40mg / 200mL in single-dose PVC flexible containers packaged in cartons containing 10 bags.

Prescribing information is available upon request from the Bedford Laboratories' professional services department at 800.521.5169, or from the company's web site, www.bedfordlabs.com.

About Bedford Laboratories

Bedford Laboratories supplies the US and International markets with multisource and specialty injectable products offering a broad range of multisource injectables across multiple therapeutic classes. Bedford Laboratories is one of the largest generic injectable pharmaceutical companies in the US.

Headquartered in Bedford, Ohio, Bedford Laboratories is a division of Ben Venue Laboratories, Inc. For more information on Bedford Laboratories, visit www.bedfordlabs.com.

About Ben Venue Laboratories, Inc.

Ben Venue Laboratories, Inc. was founded in 1938 and is a leading contract manufacturer of highly complex, sterile injectable drug products for the global pharmaceutical industry. Ben Venue has been under contract with the National Cancer Institute since 1967 to develop parenteral dosage forms for many anticancer agents. It has also manufactured various AIDS-specific drugs in conjunction with the NCI. Ben Venue employs more than 1,300 people.  For more information on Ben Venue Laboratories and current career opportunities, visit www.benvenue.com.

Ben Venue is a U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies (Ingelheim, Germany). For more information, please visit http://us.boehringer-ingelheim.com.

Primacor® is a registered trademark of Sanofi-Aventis

SOURCE Bedford Laboratories

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED